Page last updated: 2024-08-21

dehydroepiandrosterone sulfate and Idiopathic Pulmonary Fibrosis

dehydroepiandrosterone sulfate has been researched along with Idiopathic Pulmonary Fibrosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Funke-Chambour, M; Geiser, TK; Guler, SA; Kocher, G; Machahua, C; Marti, TM; Ryerson, CJ; Tan, B; Trappetti, V1
Barrera, L; Becerril, C; Chavira, R; Lozano, A; Mendoza-Milla, C; Montaño, M; Morales, V; Pardo, A; Rangel, C; Ruiz, V; Selman, M; Valero Jiménez, A1

Other Studies

2 other study(ies) available for dehydroepiandrosterone sulfate and Idiopathic Pulmonary Fibrosis

ArticleYear
Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study.
    Respiratory research, 2022, Jun-08, Volume: 23, Issue:1

    Topics: Dehydroepiandrosterone Sulfate; Female; Fibrosis; Humans; Idiopathic Pulmonary Fibrosis; Lung; Lung Diseases, Interstitial; Male

2022
Dehydroepiandrosterone has strong antifibrotic effects and is decreased in idiopathic pulmonary fibrosis.
    The European respiratory journal, 2013, Volume: 42, Issue:5

    Topics: Aged; Apoptosis; Bronchoalveolar Lavage; Case-Control Studies; Caspase 9; Cell Differentiation; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Collagen; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Fibroblasts; Gene Expression Profiling; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Platelet-Derived Growth Factor; Transforming Growth Factor beta1

2013